MARY MULHALL: Open Payments
NPI 1457862286 · AUGUSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$763 in 43 payments from 12 companies in 2025. Trend: 2023 $1,028 · 2024 $1,140 · 2025 $763
Food & beverage: $763
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 17 | $257 |
| Abbott Laboratories | 7 | $147 |
| Lilly USA, LLC | 4 | $68 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $51 |
| Axsome Therapeutics, Inc. | 2 | $46 |
| ABBVIE INC. | 3 | $45 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $44 |
| PFIZER INC. | 1 | $34 |
| Stryker Corporation | 1 | $26 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
Products named: Ozempic, FREESTYLE LIBRE 3, MOUNJARO, Wegovy, XIFAXAN, Sunosi, Kerendia, ELIQUIS.
Industry payments across GA — which companies pay providers there.
